Articles producció científica> Medicina i Cirurgia

Stratification of cancer and diabetes based on circulating levels of formate and glucose

  • Identification data

    Identifier: imarina:4943960
    Authors:
    Pietzke, MatthiasFernandez Arroyo, SalvadorSumpton, DavidMackay, Gillian M.Martin-Castillo, BegonaCamps, JordiJoven, JorgeMenendez, Javier A.Vazquez, AlexeiPernas, SoniaDorca, JoanAlvarez-Lopez, IsabelMartinez, SusanaManuel Perez-Garcia, JoseBatista Lopez, NorbertoRodriguez-Sanchez, Cesar A.Amillano, KepaDominguez Fernandez, SeverinaLuque-Cabal, MariaMorilla, IdoiaVinas, GemmaCortes, JavierMETTEN Study Grp
    Abstract:
    BackgroundSerum and urine metabolites have been investigated for their use as cancer biomarkers. The specificity of candidate metabolites can be limited by the impact of other disorders on metabolite levels. In particular, the increasing incidence of obesity could become a significant confounding factor.MethodsHere we developed a multinomial classifier for the stratification of cancer, obesity and healthy phenotypes based on circulating glucose and formate levels. We quantified the classifier performance from the retrospective analysis of samples from breast cancer, lung cancer, obese individuals and healthy controls.ResultsWe discovered that circulating formate levels are significantly lower in breast and lung cancer patients than in healthy controls. However, the performance of a cancer classifier based on formate levels alone is limited because obese patients also have low serum formate levels. By introducing a multinomial classifier based on circulating glucose and formate levels, we were able to improve the classifier performance, reaching a true positive rate of 79% with a false positive rate of 8%.ConclusionsCirculating formate is reduced in HER2+ breast cancer, non-small cell lung cancer and highly obese patients relative to healthy controls. Further studies are required to determine the relevance of these observations in other cancer types and diseases.
  • Others:

    Author, as appears in the article.: Pietzke, Matthias; Fernandez Arroyo, Salvador; Sumpton, David; Mackay, Gillian M.; Martin-Castillo, Begona; Camps, Jordi; Joven, Jorge; Menendez, Javier A.; Vazquez, Alexei; Pernas, Sonia; Dorca, Joan; Alvarez-Lopez, Isabel; Martinez, Susana; Manuel Perez-Garcia, Jose; Batista Lopez, Norberto; Rodriguez-Sanchez, Cesar A.; Amillano, Kepa; Dominguez Fernandez, Severina; Luque-Cabal, Maria; Morilla, Idoia; Vinas, Gemma; Cortes, Javier;METTEN Study Grp
    Department: Medicina i Cirurgia
    URV's Author/s: Camps Andreu, Jorge / Joven Maried, Jorge
    Keywords: Serum metabolomics Hepatocellular-carcinoma Cancer serum metabolomics serum formate obesity nmr metabolomics analysis lung-cancer identify formate chemotherapy cancer biomarker
    Abstract: BackgroundSerum and urine metabolites have been investigated for their use as cancer biomarkers. The specificity of candidate metabolites can be limited by the impact of other disorders on metabolite levels. In particular, the increasing incidence of obesity could become a significant confounding factor.MethodsHere we developed a multinomial classifier for the stratification of cancer, obesity and healthy phenotypes based on circulating glucose and formate levels. We quantified the classifier performance from the retrospective analysis of samples from breast cancer, lung cancer, obese individuals and healthy controls.ResultsWe discovered that circulating formate levels are significantly lower in breast and lung cancer patients than in healthy controls. However, the performance of a cancer classifier based on formate levels alone is limited because obese patients also have low serum formate levels. By introducing a multinomial classifier based on circulating glucose and formate levels, we were able to improve the classifier performance, reaching a true positive rate of 79% with a false positive rate of 8%.ConclusionsCirculating formate is reduced in HER2+ breast cancer, non-small cell lung cancer and highly obese patients relative to healthy controls. Further studies are required to determine the relevance of these observations in other cancer types and diseases.
    Thematic Areas: Oncology Endocrinology, diabetes and metabolism Ciencias sociales Cell biology Cancer research
    licence for use: https://creativecommons.org/licenses/by/3.0/es/
    ISSN: 20493002
    Author's mail: jorge.camps@urv.cat jorge.joven@urv.cat
    Author identifier: 0000-0002-3165-3640 0000-0003-2749-4541
    Record's date: 2024-09-07
    Papper version: info:eu-repo/semantics/publishedVersion
    Link to the original source: https://cancerandmetabolism.biomedcentral.com/articles/10.1186/s40170-019-0195-x
    Licence document URL: https://repositori.urv.cat/ca/proteccio-de-dades/
    Papper original source: Cancer Metab. 7 (3): 3-
    APA: Pietzke, Matthias; Fernandez Arroyo, Salvador; Sumpton, David; Mackay, Gillian M.; Martin-Castillo, Begona; Camps, Jordi; Joven, Jorge; Menendez, Javi (2019). Stratification of cancer and diabetes based on circulating levels of formate and glucose. Cancer Metab, 7(3), 3-. DOI: 10.1186/s40170-019-0195-x
    Article's DOI: 10.1186/s40170-019-0195-x
    Entity: Universitat Rovira i Virgili
    Journal publication year: 2019
    Publication Type: Journal Publications
  • Keywords:

    Cell Biology,Oncology
    Serum metabolomics
    Hepatocellular-carcinoma
    Cancer
    serum metabolomics
    serum formate
    obesity
    nmr
    metabolomics analysis
    lung-cancer
    identify
    formate
    chemotherapy
    cancer
    biomarker
    Oncology
    Endocrinology, diabetes and metabolism
    Ciencias sociales
    Cell biology
    Cancer research
  • Documents:

  • Cerca a google

    Search to google scholar